메뉴 건너뛰기




Volumn 2, Issue 4, 2002, Pages 329-345

The promise and obstacle of p53 as a cancer therapeutic agent

Author keywords

Cancer therapy; Gene therapy; p53

Indexed keywords

1 ETHYL 2 [[3 ETHYL 5 (3 METHYLBENZOTHIAZOLIN 2 YLIDENE) 4 OXOTHIAZOLIDIN 2 YLIDENE]METHYL]PYRIDINIUM CHLORIDE; 4 (3 DIMETHYLAMINOPROPYLAMINO) 2 (4 METHOXYSTYRYL)QUINAZOLINE; ANTINEOPLASTIC AGENT; CARBOXYL GROUP; CD40 LIGAND; CHAPERONE; CISPLATIN; CRE RECOMBINASE; DACTINOMYCIN; EPSTEIN BARR VIRUS ANTIGEN; FLUOROURACIL; GANCICLOVIR; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IRINOTECAN; LEPTOMYCIN B; LIPOSOME; MUTANT PROTEIN; P53 BINDING PROTEIN DERIVATIVE; PACLITAXEL; PRIMA 1; PROTEIN CTS; PROTEIN MDM2; PROTEIN P53; PROTEIN P63; PROTEIN P73; RIBOZYME; THYMIDINE KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIRUS PROTEIN;

EID: 0036625964     PISSN: 15665240     EISSN: None     Source Type: Journal    
DOI: 10.2174/1566524023362474     Document Type: Review
Times cited : (45)

References (156)
  • 9
    • 0030941458 scopus 로고    scopus 로고
    • Levine, A.J. (1997) Cell, 88, 323-31.
    • (1997) Cell , vol.88 , pp. 323-331
    • Levine, A.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.